Cardiac POC is a medical test performed near to the site of the patient. The Cardiac POCs are simple medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include Troponin and brain natriuretic peptide tests, which are used to diagnose cardiovascular conditions such as acute myocardial infarction, coronary syndromes and heart failure. These tests help in the detection of enzymes released during failure of the heart and in critical cardiac conditions such as creating kinase, troponin, lactate dehydrogenase isoenzymes and brain natriuretic peptides. Research Beam Model: Research Beam Product ID: 20848 2500 USD New
Global Cardiac POC Market 2014-2018
 
 

Global Cardiac POC Market 2014-2018

  • Category : Healthcare
  • Published On : August   2014
  • Pages : 63
  • Publisher : Technavio
 
 
 

"About Cardiac POC

Cardiac POC is a medical test performed near to the site of the patient. The Cardiac POCs are simple medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include Troponin and brain natriuretic peptide tests, which are used to diagnose cardiovascular conditions such as acute myocardial infarction, coronary syndromes and heart failure. These tests help in the detection of enzymes released during failure of the heart and in critical cardiac conditions such as creating kinase, troponin, lactate dehydrogenase isoenzymes and brain natriuretic peptides. The Cardiac POC tests helps to understand and differentiate better between myocardial infarction and angina, which help to diagnose the patient for a specific disease. These tests or assays offer reliable measurement of the markers, released during heart failure, and provide results within one hour of testing. In addition, to save time, a few Cardiac POC tests have been modified to measure enzymes to reduce operational error and simplify performance. Thus, these tests help significantly in reducing the turnaround time from testing to end results by allowing immediate patient response and effective treatment, or the discharge of patients.

TechNavio's analysts forecast the Global Cardiac POC market will grow at a CAGR of 14.40 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and growth prospects of the Global Cardiac POC market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of two type of tests: Troponin and brain natriuretic peptide tests, which are used to treat Cardiac POC. Furthermore, the report considers revenue generated from the following type of tests - Biosite Triage, Cobas and i-STAT.

The report also presents the vendor landscape and a corresponding detailed analysis of the top three vendors in the Global Cardiac POC market. In addition, it discusses the major drivers that influence the growth of the Global Cardiac POC market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.

TechNavio's report, the Global Cardiac POC Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cardiac POC market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas 

• EMEA        

• APAC

Key Vendors

• Alere Inc.

• Abbott Laboratories

• Roche Diagnostics 

Other Prominent Vendors

 • Beckman Coulter, Inc.

• BG Medicine Inc.

• Boston Scientific Corp

• Medtronic Inc.

• Randox Laboratories Ltd.

Key Market Driver

• Increasing Incidence of Cardiac Disorders.

• For a full, detailed list, view our report.

Key Market Challenge

• Lack of  Specific Actions in Detecting the Presence of Cardiovascular Diseases.

• For a full, detailed list, view our report.

Key Market Trend

• Introduction of Enhanced Products.

• For a full, detailed list, view our report.

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?



 


01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Type of Tests

08. Global Cardiac Troponin Test Market

08.1 Market Overview

08.2 Market Size and Forecast

09. Global Cardiac BNP Test Market

09.1 Market Overview

09.2 Market Size and Forecast

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario

18.1.1 Key News

18.1.2 Mergers and Acquisitions

18.2 Market Share Analysis 2013

18.3 Other Prominent Vendors

19. Key Vendor Analysis

19.1 Abbott Laboratories

19.1.1 Key Facts

19.1.2 Business Overview

19.1.3 Business Segmentation by Revenue 2012

19.1.4 Business Segmentation by Revenue 2012 and 2013

19.1.5 Sales by Geography

19.1.6 Business Strategy

19.1.7 Key Developments

19.1.8 SWOT Analysis

19.1.9 Strengths

19.1.10 Weakness

19.1.11 Opportunities

19.1.12 Threats

19.2 Alere 

19.2.1 Business Overview

19.2.2 Business Segmentation

19.2.3 Business Segmentation by Revenue 2013

19.2.4 Geographical Segmentation by Revenue 2013

19.2.5 Business Strategy

19.2.6 Recent Developments

19.2.7 SWOT Analysis

19.2.8 Strengths

19.2.9 Weaknesses

19.2.10 Opportunities

19.2.11 Threats

19.3 Roche Diagnostics

19.3.1 Key Facts

19.3.2 Business Overview

19.3.3 Business Segmentation by Revenue 2013

19.3.4 Geographical Segmentation by Revenue 2013

19.3.5 Business Strategy

19.3.6 Recent Developments

19.3.7 SWOT Analysis

19.3.8 Strengths

19.3.9 Weaknesses

19.3.10 Opportunities

19.3.11 Threats

19.3.12 Other Reports in Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Cardiac POC Market for 2013-2018 in (US$ million)

Exhibit 3: Global Cardiac POC Market Segmentation by Type of Test

Exhibit 4: Global Cardiac POC Market Segmentation by Type of Test for 2013-2018 in (US$ million)

Exhibit 5: Global Cardiac POC Market Segmentation by Type of Test for 2013-2018

Exhibit 6: Global Cardiac Troponin Test Market 2013-2018 (US$ million)

Exhibit 7: Global Cardiac BNP Test Market 2013-2018 (US$ million)

Exhibit 8: Global Cardiac POC Market by Geographical Segmentation 2013

Exhibit 9: Global Cardiac POC Market Vendor Share Analysis 2013

Exhibit 10: Abbott Laboratories: Business Segmentation by Revenue 2012

Exhibit 11: Abbott Laboratories: Business Segmentation by Revenue 2012 and 2013 (US$ million)

Exhibit 12: Abbott Laboratories: Sales by Geography 2012

Exhibit 13: Business Segmentation of Alere 

Exhibit 14: Alere Business Segmentation by Revenue 2013

Exhibit 15: Alere Geographical Segmentation by Revenue 2013

Exhibit 16: Roche Diagnostics: Business Segmentation by Revenue 2013

Exhibit 17: Roche Diagnostics: Geographical Segmentation by Revenue 2013



PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 

Related Reports

REQUEST SAMPLE    ASK FOR DISCOUNT